Press Releases

PredictMedix Inc. Announces Filing of Two US Patents and a Sales Contract for the United Kingdom

Jul 7, 2020 - Press Releases

TORONTO, ON / ACCESSWIRE / July 7, 2020 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce the execution of a sales contract for its COVID-19 screening technology with Taurus Medical Solutions (“Taurus”), a medical distributor based out of the United Kingdom which is also a supplier to United Kingdom National Health […]

Predictmedix and Tech Mahindra to Offer AI Based Healthcare Solution for Post COVID-19 Environment

Jun 26, 2020 - Press Releases

TORONTO, ON / ACCESSWIRE / June 26, 2020 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce a collaboration with Tech Mahindra Ltd, a leading provider of digital transformation, consulting and business re-engineering services, to offer AI-Based Healthcare solutions as a part of suite of post-COVID-19 technology. The COVID-19 pandemic has brought […]

Predictmedix Announces Acquisition of Telemedicine Platform – Mobile Wellbeing

Jun 10, 2020 - Press Releases

June 10, 2020 (Source) – Predictmedix to offer a fully integrated enterprise solution for healthcare along with workplace health, safety, and compliance. Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce the acquisition of MobileWellbeing, an innovative, feature rich, Telemedicine Remote Patient Monitoring platform that will integrate with Predictmedix’s Artificial Intelligence (“AI”) driven […]

Predictmedix Inc. Announces Sales Contract for the Caribbean Region Along with Strategic Appointments and Key Partnership

Jun 4, 2020 - Press Releases

TORONTO, ON / ACCESSWIRE / June 4, 2020 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce the execution of a sales contract for its COVID-19 screening technology for the Caribbean region along with key partnerships and appointments to further bolster its position as being the provider of novel artificial intelligence […]

Predictmedix Inc. Announces a Major North American Sales Contract With Juiceworks Exhibits

May 20, 2020 - Press Releases

Predictmedix Inc. Announces a Major North American Sales Contract with Juiceworks Exhibits for its COVID-19 Mass Screening Technology TORONTO, ON / ACCESSWIRE / May 20, 2020 / Predictmedix Inc. (PMED.CN) (PMEDF) (“Predictmedix” or the “Company”) is pleased to announce the execution of a sales contract for its COVID-19 screening technology with Juiceworks Exhibits (“Juiceworks”), a […]

Predictmedix Inc. Announces Appointment of Microsoft Director of Business Development

May 12, 2020 - Press Releases

Predictmedix Inc. Announces Appointment of Microsoft Director of Business Development for AI Solutions as the Chairman of the Advisory Board  Predictmedix Bolsters its Advisory Board with Key Technology Director Kapil Raval TORONTO, ON / ACCESSWIRE / May 12, 2020 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce the appointment of […]

Predictmedix Inc. Announces Deployment of its Mass Screening Technology for Covid-19 With Max Healthcare

May 6, 2020 - Press Releases

Predictmedix launches its COVID-19 screening technology in healthcare TORONTO, ON / ACCESSWIRE / May 6, 2020 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce that the company has begun deployment of its artificial intelligence (“AI”) technology for mass screening of COVID-19 with Max Healthcare. Max Healthcare is one of the largest […]

Predictmedix Inc. Files Patent for Mass Screening for Infectious Diseases

Apr 27, 2020 - Press Releases

TORONTO, April 27, 2020 /CNW/ – Predictmedix Inc. (CSE: PMED) (OTCQB: PMEDF) (“Predictmedix” or the “Company”) is pleased to announce that it has filed Patent Application Number 63012510 – Artificial Intelligence driven rapid screening system for infectious diseases, such as SARS-CoV-2 virus responsible for COVID-19, with the United States Patent and Trademark Office. COVID-19 and […]

Clinical Experts Join Predictmedix Inc. to Advise Development of Covid-19 Screening Technology

Apr 14, 2020 - Press Releases

April 14, 2020 (Source) – Predictmedix Inc. (CNSX:PMED) (OTC:PMEDF) (formerly Cultivar Holdings Inc.) (the “Company”) has signed exclusive advisory agreements with clinicians in emergency and pulmonary medicine to aid its efforts in delivering artificial intelligence (“AI”) powered technologies for COVID-19 screening. Predictmedix Inc. is welcoming to their advisory board high profile clinical experts who are dealing […]

CSE Bulletin: Name and Symbol Change – Cultivar Holdings Inc. (CULT)

Apr 8, 2020 - Press Releases

Toronto, Ontario–(Newsfile Corp. – Le 8 avril/April 2020) – Cultivar Holdings Inc. has announced a name and symbol change to Predictmedix Inc. (PMED). Shares will begin trading under the new name and symbol on April 9, 2020. Disclosure documents are available at www.thecse.com Please note that all open orders will be cancelled at the end […]

Cultivar Holdings Inc. Announces US Listing on OTCQB Market Under Symbol CVRHF

Mar 31, 2020 - Press Releases

TheNewswire – March 31, 2020 – Cultivar Holdings Inc. (CSE:CULT) (CNSX:CULT.CN) (OTC:CVRHF) is pleased to announce that its common shares are now trading on the OTCQB Venture Marketplace (the “OTCQB Venture”), a US trading platform that is operated by the OTC Markets Group in New York. The Company is trading on the OTCQB Venture under […]

Cultivar Holdings Inc. Enhances Focus on its Predictmedix Technologies

Mar 30, 2020 - Press Releases

Cultivar Holdings Inc. Enhances Focus on its Predictmedix Technologies and Exits Jamaican Cannabis Cultivation Business Toronto, Ontario – TheNewswire – March 30, 2020 – Cultivar Holdings Inc. (CSE:CULT) (CNSX:CULT.CN) (OTC:CVRHF) (“Cultivar” or the “Company”) is pleased to announce that it has entered into a sale agreement (the “Sale Agreement”) with respect to its 49% interest […]